Proline-dependent structural and biological properties of peptides and proteins

Critical Reviews in Biochemistry and Molecular Biology

Volumn 28, Issue 1, 1993, Pages 31-81

  Yaron, Arieh ^a   Naider, Fred ^b   Scharpe, S ^c  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Aminopeptidase p; Dipeptidyl peptidase iv; HIV 1 protease; Peptidyl prolyl cis trans isomerase; Prolidase; Proline containing peptides; Prolyl endopeptidase; Prolyl peptidases

Indexed keywords

AMINOPEPTIDASE; DIPEPTIDYL PEPTIDASE IV; PROLINE; PROLINE DIPEPTIDASE; PROLYL ENDOPEPTIDASE; VIRUS ENZYME;

AMINO ACID COMPOSITION; CELLULAR IMMUNITY; CIS TRANS ISOMERISM; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME SPECIFICITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVIEW; STRUCTURE ACTIVITY RELATION; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; ANIMAL; HUMAN; MOLECULAR SEQUENCE DATA; PEPTIDE HYDROLASES; PEPTIDES; PROLINE; PROTEIN CONFORMATION; PROTEINS; SUPPORT, U.S. GOV'T, P.H.S.;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0027439867     PISSN: 10409238     EISSN: None     Source Type: Journal    
DOI: 10.3109/10409239309082572     Document Type: Article

References (383)

1. Experimental and theoretical aspects of protein folding
2. Relationship between helix-coil transition parameters for synthetic polypeptides and helix conformation parameters for globular proteins
3. Conformational parameters for amino acids in helical, p-sheet and random coi) regions calculated from proteins
4. Influence of local interactions on protein structure
5. Helix geometry in proteins
6. Proline-induced constraints in a-helices
7. Conformational studies on peptides with proline in the right-handed a-helical region
8. Proline in a-helix: stability and conformation studied by dynamics simulation, Proteins: Struct
9. The ability of the proline residue to promote successive intramolecular hydrogen bonds in oligopeptides
10. Conformations of proline residues in membrane environments
11. An explanation for the rare occurrence of cis peptide units in proteins and polypeptides
12. Energy parameters in polypeptides
13. Biological Macromolecules
14. Biological Macromolecules
15. Hypothesis about the function of membrane-buried proline residues in transport proteins
16. The X-Pro peptide bond as an NMR probe for conformational studies of flexible linear peptides
17. Nmr studies of the molecular conformations in the linear oligopeptides H-(L-Ala)„-L-Pro-OH
18. Steric effects of cis-trans isomerism on neighboring residues in proline oligopeptides: a L1C-NMR study of conformational heterogeneity in linear-tripeptides
19. Electron transfer across polypeptides. 3. Oligoproline bridging ligands
20. C-and H-NMR studies of cis-trans conformers of oligoproline
21. The chemistry and biology of collagen, in The Proteins
22. Cyclic pentapeptides as
23. Helix-coil stability constants for the naturally
24. Morphiceptin analogs containing 2-aminocyclopentane carboxylic acid as a peptidomimetic for proline
25. Thiazolidine derivatives as potent inhibitors specific for prolyl endopeptidase
26. Inhibition and active-site modelling of prolidase
27. Activation and inhibition of cerebral prolidase
28. Dipeptidyl peptidase IV in the immune system: effects of specific enzyme inhibitors on activity of dipeptidyl peptidase IV and proliferation of human lymphocytes
29. Conformational mimicry
30. Synthesis of a somatostatin analog containing a tetrazole cAs-amide bond surrogate
31. Physicochemical analysis of (Pro-Pro-Gly)n with defined molecular weight-temperature dependence of molecular weight in aqueous solution
32. Reverse Turns in Peptides and Proteins (CRC Critical Reviews in Biochemistry 8)
33. Amino acid composition of the membrane and aqueous domains of integral membrane proteins
34. Evidence for similar function of transmembrane segments in receptor and membrane-anchored proteins
35. Fourier transform infrared evidence for proline structural changes during the bacteriorhodopsin photocycle
36. Structure-Function Studies On Bacteriorhodopsin
37. A proton motive force transducer and its role in proton pumps
38. Channel formation properties of synthetic pardaxin and analogues
39. Interaction of D-amino acid incorporated analogues of pardaxin with membranes
40. Determination of cis-trans proline isomerization by trypsin proteolysis: application to a model pentapeptide and to oxidized ribonuclease A
41. Conformational specificity of chymotrypsin toward proline-containing substrates
42. Proline specific endo- and exopeptidases
43. Proline residues in the maturation and degradation of peptide hormones and neuropeptides
44. Mammalian Proteases: A Glossaiy and Bibliography
45. Mammalian Proteases: A Glossaiy and Bibliography
46. On the size of the active site in proteases. I. Papain
47. Hydrolases from Neisseria gonorrhoeae
48. Aminopeptidase P from human leukocytes
49. The cleavage of prolyl peptides by kidney peptidases
50. Enzymic properties of intestinal aminopeptidase P: a new continuous assay
51. Aminopeptidase P from bovine lung: solubilization, properties, and potential role in bradykinin degradation
52. Aminopeptidase P activity in rat organs and human serum
53. Proline-specific proteases in cultivated neuronal and glial cells
54. Purification and characterization of pig kidney aminopeptidase P: a glycosyl-phosphatidylinositol-anchored ectoenzyme
55. Is the proline-specific aminopeptidase P of the intestinal brush border an integral membrane enzyme'?
56. A kininase and a kinin converting enzyme: two alpha aminoacyl peptide hydrolases from bovine lung
57. Species variation in aminopeptidase P activity in vivo and in vitro
58. Distribution of aminopeptidase P in rat tissues
59. Characterization of guinea pig serum aminopeptidase P
60. Cleavage of the Arg'-Pro---bond of bradykinin by a human lung peptidase: isolation, characterization, and inhibition by several (3-lactam antibiotics
61. Fluorogenic substrates for bacterial aminopeptidase P and its analogs detected in human serum and calf lung
62. Kinin cleavage by intact human erythrocytes
63. Aminopeptidase P activity in human endothelium, epithelium and fibroblasts
64. Distribution of proline-specific aminopeptidases in human tissues and body fluids
65. Cloning and expression of aminopeptidase P gene from Escherichia coli HB101 and characterization of expressed enzyme
66. Sequencing and high expression of aminopeptidase P gene from Escherichia coli
67. Polyamino acids as substrates of proteolytic enzymes, in Peptides
68. Aminopeptidase P from rat brain: purification and action on bioactive peptides
69. Membrane-bound aminopeptidase P from bovine lung: its purification, properties, and degradation of bradykinin
70. Purification and characterization of guinea pig aminoacylproline hydrolase (aminopeptidase P)
71. Kininase activity in human platelets: cleavage of the Arg'-Pro2-bond of bradykinin by aminopeptidase P
72. Soluble and immobilized clostridial aminopeptidase and aminopeptidase P as metal-requiring enzymes
73. The use of synthetic polyamino acids for the detection and purification of novel proteolytic enzymes
74. Sequential hydrolysis of proline-containing peptides with immobilized aminopeptidases
75. Studies on prolyl endopeptidase from shakashimeji (Lyophyllum cinerascens): purification and enzymatic properties
76. Role of cis-trans isomerism of the peptide bond in protease specificity
77. Sequential hydrolysis of proline-containing peptides with immobilized aminopeptidases
78. An extracellular aminpeptidase from Clostridium histolyticum
79. Proline isomerization studied with proteolytic enzymes
80. A novel assay method for aminopeptidase P and partial purification of two types of the enzyme
81. High-performance liquid chromatographic separation of peptides possessing a proline residue in the amino-terminal penultimate position, and their products generated by enzymatic hydrolysis
82. Ectoenzymes of the kidney microvillar membrane
83. A radioassay for aminoacylproline hydrolase (aminopeptidase P) activity
84. Partial purification and properties of aminopeptidase P from rat lung
85. Kinin cleavage by human erythrocytes
86. Exopeptidases in human platelets: an indication for proteolytic modulation of biologically active peptides
87. Aminopeptidase P and dipeptidyl peptidase IV activity in human leukocytes and in stimulated lymphocytes
88. Peptiduria presumably caused by aminopeptidase-P deficiency
89. The role of proline in the proteolytic regulation of biologically active peptides
90. Enzymic removal of amino-terminal proline and methionine from genetically engineered proteins
91. Metabolism of bradykinin by multiple coexisting membrane-bound peptidases in lung: techniques for investigating the role of each peptidase using specific inhibitors
92. Inactivation of bradykinin in rat lung
93. Inactivation and potentiation of the effects of bradykinin
94. Chemical and enzymic studies on the aminoterminal sequence of papain
95. On proteolytic enzymes. XII. Regarding the specificity of aminopeptidase and carboxypeptidase: a new type of enzyme in the intestinal tract
96. Minireview: Prolidase and prolidase deficiency
97. Purification of an 80,000-Mr glycylprolyl peptidase from Bucteroides gingivalis
98. Purification and some properties of prolidase of swine kidney
99. Purification and specificity of pig intestinal prolidase
100. Prolidase from bovine intestine: purification and characterization
101. Purification and characterization of activated human erythrocyte prolidase
102. Characterization of prolidase I and II from erythrocytes of a control, a patient with prolidase deficiency and her mother
103. Human erythrocyte prolidase and prolidase deficiency
104. Effect of long preincubation on the two forms of human erythrocyte prolidase
105. Prolidase deficiency: biochemical classification of alleles
106. Primary structure and gene localization of human prolidase
107. Molecular basis of prolidase (peptidase D) deficiency
108. Immunoaffinity purification of human erythrocyte prolidase
109. Specificity and pH dependence for acylproline cleavage by prolidase
110. Structural properties of pig intestinal proline dipeptidase
111. Enzymatic properties of pig intestinal proline dipeptidase
112. Evidence suggesting that some proteolytic enzymes may cleave only the trans form of the peptide bond
113. Prolidase activity in brain: comparison with other organs
114. Phosphoenolpyruvate as a natural bisubstrate analogue inhibitor of pig kidney prolidase
115. Mechanism and inhibition of prolidase
116. Direct NMR evidence that prolidase is specific for the trans isomer of imidodipeptide substrates
117. A proton n.m.r. study of iminodipeptide transport and hydrolysis in the human erythrocyte
118. Studies of rat brain metabolism using proton nuclear magnetic resonance: spectral assignments and monitoring of prolidase, acetylcholinesterase, and glutaminase
119. Isolation and characterization of proline peptidase mutants of Salmonella typhimurium
120. Structural organization of the gene for human prolidase (peptidase D) and demonstration of a partial gene deletion in a patient with prolidase deficiency
121. Further mapping of markers around the centromere of human chromosome 19
122. Regional mapping of human chromosome 19: organization of genes for plasma lipid transport (APOC1, -C2, and -E and LDLR) and the genes C3, PEPD, and GPI
123. Genetic linkage between the loci for myotonic dystrophy and prolidase D
124. HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins
125. Viral proteinases
126. Processing of human immunodeficiency virus polyproteins by bacterially expressed HIV-1 proteinase, in Current Communications in Molecular Biology: Viral Proteinases as Targets for Chemotherapy
127. Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor
128. Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease
129. Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides
130. An 11-kDa form of human immunodeficiency virus protease expressed in Escherichia coli is sufficient for enzymatic activity
131. Active site mutagenesis of the AIDS virus protease and its alleviation by trans complementation
132. Human immunodeficiency viral protease is catalytically active as a fusion protein: characterization of the fusion and native enzymes produced in Escherichia coli
133. Viral proteinases: weakness in strength
134. Cleavage of Rous sarcoma viral polypeptide precursor into internal structural proteins in vitro involves viral protein pi5
135. Proteolytic processing of avian sarcoma and leukosis viruses pol-endo recombinant proteins reveals another pol gene domain
136. Biochemical properties of pl5-associated protease in an avian RNA tumor virus
137. Murine leukemia virus protease is encoded by the gag-pol gene and is synthesized through suppression of an amber termination codon
138. Translational readthrough of an amber termination codon during synthesis of feline leukemia virus protease
139. Bovine leukemia virus protease: purification, chemical analysis, and in vitro processing of gag precursor polyproteins
140. Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli
141. Partial purification and substrate analysis of bacterially expressed HIV protease by means of monoclonal antibody
142. Processing protease and reverse transcriptase from human immunodeficiency virus type 1 polyprotein in Escherichia coli
143. Human immunodeficiency virus protease: bacterial expression and characterization of the purified aspartic protease
144. Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease
145. Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A
146. Crystallizable HIV-1 protease derived from expression of the viral pol gene in Escherichia coli
147. Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2
148. High-level synthesis of recombinant HIV-1 protease and the recovery of active enzyme from inclusion bodies
149. Expression in Escherichia coli of the AIDS virus aspartic protease through a protein fusion
150. Processing of in Wrro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli
151. Characterization and autoprocessing of precursor and mature forms of human immunodeficiency virus type 1 (HIV 1) protease purified from Escherichia coli
152. Genetic locus, primary structure, and chemical synthesis of human immunodeficiency virus protease
153. Chemical synthesis and enzymatic activity of a 99-residue peptide with a sequence proposed for the human immunodeficiency virus protease
154. Affinity purification of HIV-1 and HIV-2 proteases from recombinant E. coli strains using pepstatin-agarose
155. Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease
156. Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1
157. Design, activity and 2.8 A crystal structure of a C, symmetric inhibitor complexed to HIV-1 protease
158. X-ray analysis of HIV-1 proteinase at 2.7 A resolution confirms structural homology among retorviral enzymes
159. Crystal structure of a retroviral protease proves relationship to aspartic protease family
160. Crystalization of the aspartylprotease from the human immunodeficiency virus, HIV-1
161. Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor
162. Mutational analysis of human immunodeficiency virus type 1 protease suggests functional homology with aspartic proteinases
163. A structural model for the retroviral proteases
164. Domain communication in the dynamical structure of human immunodeficiency virus 1 protease
165. Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases
166. Molecular modeling of the HIV-1 protease its substrate binding site
167. Evaluation of homology modelling of HIV protease
168. Specificity and inhibition of proteases from human immunodeficiency virus 1 and 2
169. Synthetic peptides as substrates and inhibitors of a retroviral protease
170. Molecular cloning and polymorphism of the human immune deficiency virus type 2
171. Genome organization and transactivation of the human immunodeficiency virus type 2
172. Synthetic HIV-2 protease cleaves the GAG precursor of HIV-1 with the same specificity as HIV-1 protease
173. Sequence specificity of retroviral proteases
174. Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors
175. Synthetic peptides as substrates and inhibitors of human immune deficiency virus-1 protease
176. Peptide substrates and inhibitors of the HIV-1 protease
177. Inhibitors of HIV protease based on modified peptide substrates
178. Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase
179. Complete nucleotide sequence of the AIDS virus, HTLV-III
180. Avian retroviral protease and cellular aspartic proteases are distinguished by activities on peptide substrates
181. Active human immunodeficiency virus protease is required for viral infectivity
182. A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins
183. Murine leukemia virus maturation: protease region required for conversion from immature to mature core form and for virus infectivity
184. Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity
185. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1
186. Dipeptidyl peptidase IV, a kidney brush-border serine peptidase
187. A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-(3-naphthylamide
188. Biogenesis of plasma membrane glycoproteins: purification and properties of two rat liver plasma membrane glycoproteins
189. Dipeptidyl aminopeptidase IV from porcine pancreas
190. Biochemical characterization of domain-specific glycoproteins of the rat hepatocyte plasma membrane
191. Comparative studies of the sugar chains of aminopeptidase N and dipeptidylpeptidase IV purified from rat kidney brush-border membrane
192. Primary structure of rat liver dipeptidyl peptidase IV deduced from its cDNA and identification of the NH2-terminal signal sequence as the membrane-anchoring domain
193. Isolation and characterization of dipeptidyl peptidase IV from human placenta
194. Purification of dipeptidyl-aminopeptidase IV from human kidney by anti-dipeptidyl-aminopeptidase IV affinity chromatography
195. Purification and properties of dipeptidyl peptidase IV from human urine
196. Isolation and characterization of dipeptidyl aminopeptidase IV from human kidney cortex
197. Characterization of dipeptidyl peptidase IV from lymphocytes of chronic lymphocytic leukemia of T type
198. Characterization of dipeptidylpeptidase IV (CD26) from human lymphocytes
199. Isolierung und Characterisierung der Dipeptidyl Peptidase IV aus Humanen Seminalplasma
200. Dipeptidyl aminopeptidase IV, a glycoprotein from pig kidney
201. Proteins of the kidney microvillar membrane: the amphipathic form of dipeptidyl peptidase IV
202. Anchoring and biosynthesis of stalked brush border membrane proteins: glycosidases and peptidases of enterocytes and renal tubuli
203. Immunohistochemical localization of dipeptidyl aminopeptidase IV in rat kidney, liver, and salivary glands
204. Cell surface expression by adult rat hepatocytes of a non-collagen glycoprotein present in rat liver biomatrix
205. Identification of dipeptidyl peptidase IV as a protein shared by the plasma membrane of hepatocytes and liver biomatrix
206. Identification of rat hepatocyte plasma membrane proteins using monoclonal antibodies
207. Quantitative immunogold localization of dipeptidyl peptidase IV (DPP IV) in rat liver cells
208. Studies on glycy-proline naphthylamidase. I. Lymphocytes
209. Dipeptidyl peptidase IV as a new surface marker for a subpopulation of human T-lymphocytes
210. Dipeptidyl peptidase IV of human lymphocytes. Evidence for specific hydrolysis of glycylproline (3-nitroanilide in T-lymphocytes
211. The importance of protease histochemistry in pathology
212. Cytochemical reactivity of T|x lymphocytes in human lymphatic tissue for dipeptidylaminopeptidase IV
213. Enzyme histochemical staining of T(JL lymphocytes for glycyl-proline-4-methoxy-|3-naphthylamide-peptidase (DAP IV)
214. Stepwise cleavage of the Pro part of promelittin by dipeptidylpeptidase IV
215. Post-proline dipeptidyl aminopeptidase from Flavobacterium
216. Proline-specific dipeptidyl aminopeptidase from Flavobacterium meningosepticum
217. Purification and properties of dipeptidyl peptidase IV from Streptococcus mitis ATCC 9811
218. Localization of the thermosensitive X-prolyl dipeptidyl aminopeptidase in the vacuolar membrane of Saccharomyces cerevisiae
219. Membrane orientation of rat gpllO as studied by in vitro translation
220. Immunoelectrophoretic analysis of vascular, membrane-bound angiotensin I converting enzyme, aminopeptidase M, and dipeptidyl(amino)peptidase IV
221. Kinetische Untersuchungen an der Dipeptidyl-peptidase IV
222. Post-proline cleaving enzyme and post-proline dipeptidyl aminopeptidase: comparison of two peptidases with high specificity for proline residues
223. Rapid chromatographic purification of dipeptidyl peptidase IV in human submaxillary gland
224. Cloning and functional expression of the T cell activation antigen CD26
225. Dipeptidyl peptidase IV (CD26) gene expression in enterocyte-like colon cancer cell lines HT-29 and Caco-2: cloning of the complete human coding sequence and changes of dipeptidyl peptidase IV mRNA levels during cell differentiation
226. cDNA cloning for a bile canaliculus domain-specific membrane glycoprotein of rat hepatocytes
227. Expression of dipeptidyl peptidase IV in rat tissues is mainly regulated at the mRNA levels
228. Proteins of the kidney microvillar membrane: the amphipathic form of dipeptidyl peptidase IV
229. Soluble dipeptidyl peptidase IV from terminal differentiated rat epidermal cells: purification and its activity on synthetic and natural peptides
230. New chromogenic substrates for X-prolyl dipeptidyl-aminopeptidase
231. GJycylprolyl (3-naphthylamidase activity in human serum
232. A new assay of X-prolyl dipeptidyl-aminopeptidase activity in human serum with glycylproline p-phenylazoanilide as substrate
233. A kinetic fluorometric assay of dipeptidyl peptidase IV in viable human blood mononuclear cells
234. Fluorescence assay of X-prolyl dipeptidyl-aminopeptidase activity with a new fluorogenic substrate
235. Assay of dipeptidyl peptidase IV in serum by fluorometry of 4-methoxy-2-naphthylamine
236. Post-proline cleaving enzyme: purification of this endopeptidase by affinity chromatography
237. The conformation around the peptide bond between the P1- and P2-positions is important for catalytic activity of some proline-specific proteases
238. Are diprotin A (Ile-Pro-Ile) and diprotin B (Val-Pro-Leu) inhibitors or substrates of dipeptidyl peptidase IV?
239. Depth of side-chain pocket in the S, subsite of dipeptidyl peptidase IV
240. Rat intestinal brush border membrane dipeptidyl-aminopeptidase IV: kinetic properties and substrate specificites of the purified enzyme
241. Inhibitory action of proline-containing peptides on Xaa-Pro-dipeptidylaminopeptidase
242. Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T cell function
243. Diacylhydroxylamines as enzyme-activated inhibitors for serine proteases
244. Dipeptidylpeptidase IV — inacitvation with A'-peptidyl-O-aroyl hydroxylamines
245. Reactions between dipeptidyl peptidase IV and diacyl hydroxylamines: mechanistic investigations
246. Diprotins A and B, inhibitors of dipeptidyl aminopeptidase IV, produced by bacteria
247. Involvement of dipeptidyl peptidase IV in an in vivo immune responsse
248. Successive cleavage of N-terminal Arg'-Pro- and Lys3-Pro4 from substance P but no release of Arg'-Pro2 from bradykinin, by X-Pro dipeptidyl-aminopeptidase
249. Liver dipeptidyl aminopeptidase IV hydrolyzes substance P
250. Conversion of substance P to C-terminal fragments in human plasma
251. Synthese und enzymatischer Abbau von β-casomorphin-5
252. Studies on the enzymatic degradation of (3-casomorphins, Life Sciences
253. Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma
254. The degradation of bioactive peptides and proteins by dipeptidyl peptidase IV from human placenta
255. Intestinal assimilation of a proline-containing tetrapeptide: role of a brush border membrane post-proline dipeptidyl aminopeptidase IV
256. A negative blood-clotting factor lining the vessels
257. Biosynthesis of winter flounder antifreeze proprotein in E. coli
258. Role of dipeptidyl peptidase IV in uptake of peptide nitrogen from 3-casomorphin in rabbit renal BBMV
259. Hydrolysis and transport of proline-containing peptides in renal brush-border membrane vesicles from dipeptidyl peptidase IV-positive and dipeptidyl peptidase IV-negative rat strains
260. Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix
261. Involvement of plasma membrane dipeptidyl peptidase IV in fibronectin-mediated adhesion of cells on collagen
262. Direct evidence for the binding of rat liver DPP IV to collagen in vitro
263. A collagen-binding glycoprotein on the surface of mouse fibroblasts is identified as dipeptidyl peptidase IV
264. Dipeptidyl peptidase IV—subcellular localization, activity and kinetics in lymphocytes from control subjects, immunodeficient patients and cord blood
265. Ta., a novel 105 kDa human T cell activation antigen defined by a monoclonal antibody
266. CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as characterized by monoclonal antibodies clone Til-19-4-7 and 4EL1C7
267. Immunochemical analysis of the T cell-specific antigens, in Leukocytes Typing II
268. The T cell triggering molecule Tpl03 is associated with dipeptidyl aminopeptidase IV activity
269. Proteinases in pathology: usefulness of histochemical methods
270. Internalization of interleukin 2 is mediated by the p chain of the high-affinity interleukin 2 receptor
271. Human U937 cell surface peptidase activities: characterization and degradative effect on tumor necrosis factor-a
272. Interleukin 2 production by human T lymphocytes identified by antibodies to dipeptidyl peptidase IV
273. The dipeptidyl peptidase IV, a membrane enzyme involved in the proliferation of T lymphocytes
274. Dipeptidyl peptidase IV in human T lymphocytes: Impaired induction of interleukin 2 and gamma interferon due to specific inhibition of dipeptidyl peptidase IV
275. Dipeptidyl peptidase IV (DP IV), a functional marker of the T lymphocyte system
276. Dipeptidyl peptidase IV in the immune system: cytofluorometric evidence for induction of the enzyme on activated T lymphocytes
277. Cell surface modulation of CD26 by anti-lF7 monoclonal antibody: analysis of surface expression and human T cell activation
278. Coassociation of CD26 (dipeptidyl peptidase IV) with CDE45 on the surface of human T lymphocytes
279. Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes
280. Human CD4 helper T cell activation: functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family
281. Yeast a factor is processed from a larger precursor polypeptide: the essential role of a membrane-bound dipeptidyl aminopeptidase
282. Properties and activities of aminopeptidases in normal and mitogen-stimulated human lymphocytes
283. Purification of two dipeptidyl aminopeptidases II from rat brain and their action on proline-containing neuropeptides
284. A novel dipeptidyl peptidase II from the porcine ovary: purification and characterization of a lysosomal serine protease showing enhanced specificity for prolyl bonds
285. Leucylglyciniamide released from oxytocin by human uterine enzyme
286. Minireview: Prolyl endopeptidase
287. Immunological, physical, and chemical evidence for the identity of brain and kidney post-proline cleaving enzyme
288. Immunochemical characterization of a proline endopeptidase from rat brain
289. New fluorogenic substrates for a rat brain proline endopeptidase
290. Isolation and characterization of prolyl endopeptidase from eggs of the solitary ascidian Halocynthia roretzi: comparison with the sperm enzyme
291. Post-proline cleaving enzyme from lamb brain
292. Post-proline cleaving enzyme (prolyl endopeptidase) from bovine brain
293. Characterization of proline endopeptidase from rat brain
294. Isolation and characterization of a post-proline cleaving enzyme and its inhibitor from sperm of the ascidian Halocynthia roretzi
295. Purification and properties of a prolyl endopeptidase from rabbit brain
296. Proline-specific endopeptidase from Flavobacterium meningosepticum: physico-chemical properties
297. Characterization of a prolyl endopeptidase from Flavobacterium meningosepticum: complete sequence and localization of the active site serine
298. Prolyl endopeptidase from Flavobacterium meningosepticum: cloning and sequencing of the enzyme gene
299. cDNA Cloning of porcine brain prolyl endopeptidase and identification of the active-site seryl residue
300. The molecular evolution of genes and proteins: a tale of two serines
301. Proline-specific endopeptidase from Flavobacterium: purification and properties
302. Specificity of prolyl endopeptidase
303. Evidence showing that a proline-specific endopeptidase has an absolute requirement for a trans peptide bond immediately preceding the active bond
304. Postproline cleaving enzyme: kinetic studies of size and stereospecificity of its active site
305. Postproline cleaving enzyme: identification as serine protease using active site specific inhibitors
306. Inhibition of rabbit brain prolyl endopeptidase by /V'-benzyloxycarbonyl-prolyl-prolinal, a transition state aldehyde inhibitor
307. Prolyl endopeptidase: inhibition in vivo by iV-benzyloxycarbonyl-prolyl-prolinal
308. N-Benzyloxycarbonyl-valyl-prolinal, a potent inhibitor of post-proline cleaving enzyme
309. Synthesis and structure of prolinal-containing peptides, and their use as specific inhibitors of prolyl endo-peptidases
310. Comparison of inhibitory effects of prolinal-containing peptide derivatives on prolyl endopeptidases from bovine brain and Flavobacterium
311. Specific inhibition of post proline cleaving enzyme by benzyloxycar-bonyl-Gly-Pro-diazomethyl ketone
312. Post-proline cleaving enzyme: synthesis of a new fluorogenic substrate and distribution of the endopeptidase in rat tissues and body fluids of man
313. Brain peptidases: their possible neuronal and glial localization
314. Cleavage of substance P to an N-terminal tetrapeptide and a C-terminal heptapeptide by a post-proline cleaving enzyme from bovine brain
315. Porcine muscle prolyl endopeptidase and its endogenous substrates
316. Porcine muscle prolyl endopeptidase: limited proteolysis of tryptic peptides from hemoglobin p-chains at prolyl and alanyl bonds
317. Processing of angiotensin peptides by NG108-15 neuroblastoma X glioma hybrid cell line
318. Specific inhibitors for prolyl endopeptidase and their anti-amnesic effect
319. Central target for the behavioural effects of vasopressin neuropeptides
320. Changes in prolyl endopeptidase during maturation of rat brain and hydrolysis of substance P by the purified enzyme
321. An inhibitor of proline endopeptidase: purification from rat brain and characterization
322. An inhibitor for post-proline cleaving enzyme: distribution and partial purification from porcine pancreas
323. Depression of prolylendopeptidase activity in the delayed hypersensitive guinea pig skin lesion induced by bovine gamma-globulin
324. Proline iminopeptidase
325. Proline iminopeptidase: II. Purification and comparison with iminodipeptidase (prolinase)
326. Proline iminopeptidase from Bacillus coagulans: purification and enzymatic properties
327. Complementary DNA encoding the human T-cell FK506-binding protein, a peptidylprolyl cis-trans isomerase distinct from cyclophilin
328. Purification and properties of proline iminopeptidase from apricot seeds
329. Beschreibung einer Proliniminopeptidase aus Euglena gracilis
330. The purification of a bovine kidney enzyme which cleaves melanocyte-stimulating hormone-release inhibiting factor
331. Prolyl aminopeptidase from rat brain and kidney: action on peptides and identification as leucyl aminopeptidase
332. Structural and immunological evidence for the identity of prolyl aminopeptidase with leucyl aminopeptidase
333. Prolinase and non-specific dipeptidase of human kidney
334. Human cytosolic carnosinase: evidence of identity with prolinase, a non-specific dipeptidase
335. NMR studies of the rates of proline cis-trans isomerization in oligopeptides
336. Mechanistic studies of peptidyl prolyl cis-trans isomerase: evidence for catalysis by distortion, Biochemistry
337. Nachweis einer Enzymkatalyse fur die cis-trans-Isomerisierung der Peptidbindung in Prolinhaltigen Peptiden
338. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins
339. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A- binding protein cyclophilin
340. Cloning, expression, and purification of human cyclophilin in Escherichia coli' and assessment of the catalytic role of cysteines by site-directed mutagenesis
341. Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK-506 binding protein: evidence for the existence of a family of distinct enzymes
342. Cyclophilin: a specific cytosolic binding protein for cyclosporin A
343. Yeast cyclophilin: isolation and characterization of the protein
344. Cyclosporin A-binding protein (cyclophilin) of Neurospora crassa
345. Isolation and amino acid sequence of cyclophilin
346. Complementary DNA for human T-cell cyclophilin
347. Cyclophilin: distribution and variant properties in normal and neoplastic tissues
348. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin
349. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase
350. FKB1 encodes a nonessential FK 506-binding protein in Saccharomyces cerevisiae and contains regions suggesting homology to the cyclophilins
351. Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and Rapamycin
352. Solution structure of the major binding protein for the immunosuppressant FK506
353. Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex
354. Kinetic (3-deuterium isotope effects suggest a covalent mechanism for the protein folding enzyme peptidylprolyl cis/trans-isomerase
355. A Candida albicans homolog of a human cyclophilin gene encodes a peptidylprolyl cis-trans isomerase
356. Chemistry and biology of the immunophilins and their immunosuppressive ligands
357. Consideration of the possibility that the slow step in protein denaturation reactions is due to cis-trans isomerism of proline residues
358. Role of proline peptide bond isomerization in unfolding and refolding of ribonuclease
359. Catalysis of protein folding by prolyl isomerase
360. Folding of ribonculease Tl. 1. Existence of multiple unfolded states created by proline isomerization
361. Folding of ribonuclease Tl. 2. Kinetic models for the folding and unfolding reactions
362. Conformation states of concanavalin A: kinetics of transitions induced by interaction with Mn;+ and Ca1* ions
363. Isolation and sequence of an FK506-binding protein from N. crassa which catalyses protein folding
364. The mechanism of protein folding: implications of in vitro refolding models for de novo protein folding and translocation in the cell
365. Probing immunosuppressant action with a nonnatural immunophilin Iigand
366. The processing of peptide precursors: Proline-directed arginyl cleavage and other monobasic processing mechanisms